N-methoxyindole-3-carbinol: an inducer of cytochrome p-450 1A1 in cultured cells; a degradation product of 1-methyl-3-indolylmethyl glucosinolate; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 398553 |
| CHEMBL ID | 1983507 |
| SCHEMBL ID | 20855303 |
| MeSH ID | M0366094 |
| Synonym |
|---|
| NCI60_038421 |
| nsc708489 |
| nsc-708489 |
| (1-methoxyindol-3-yl)methanol |
| 1h-indole-3-methanol, 1-methoxy- |
| 110139-35-0 |
| CHEMBL1983507 |
| 1-methoxy-1h-indole-3-methanol |
| DTXSID90327975 |
| n-methoxyindole-3-carbinol |
| (1-methoxy-1h-indol-3-yl)methanol |
| (1-methoxy-1h-indol-3-yl)-methanol |
| SCHEMBL20855303 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.82) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||